Published 1/17/19 on Cision PR Web High caffeine tea brand takes on energy drink incumbents with new line of iced tea energy beverages. BALTIMORE (PRWEB) JANUARY 17, 2019 Zest Tea, maker of high-caffeine tea beverages, has secured $1 million in a …
Published on the A. James Clark School of Engineering Website, 1/11/19 The University of Maryland, College Park and the University of Maryland, Baltimore celebrated the launch of the Robert E. Fischell Institute for Biomedical Devices on Thursday, January 3, 2019. With support from both campuses and …
Published 12/11/18 on Baltimore Business Journal A Pigtown-based startup that markets high-caffeine, energizing tea blends has raised $1 million in new funding. Zest Tea’s new round was co-led by the Lord Baltimore Capital Group and the University System of …
Published 11/28/18 on UMB News If there is one takeaway from this morning’s panels,” said Donald Tobin, JD, dean of the University of Maryland Francis King Carey School of Law while addressing a room full of farmers, lawyers, environmentalists, and students, “it’s that …
Published 11/29/18 on UMB News Daniel Mullins, PhD, works for the University of Maryland, Baltimore(UMB) and is a professor and department chair at the University of Maryland School of Pharmacy (UMSOP). Stephen Thomas, PhD, is a professor at the University of Maryland College Park (UMCP) in …
Published 11/28/18 on UMB News Researchers at the Institute for Bioscience and Biotechnology Research (IBBR) recently received $3.9 million from the National Institutes of Health (NIH) to develop a multi-specific, single agent antibody therapeutic against HIV-1 to block virus infection and to …
Posted 11/21/18 on Technical.ly Baltimore The work at the University of Maryland aims to contribute to treatments that could lead to “HIV remission and possible eradication.” A team of Maryland researchers is leading an effort to develop a new HIV …
Submitted by Timna Wyckoff on November 20, 2018 – 10:15 Multi-specific anti-HIV antibodies that neutralize almost all circulating HIV-1 viruses will be optimized to target persistent infection IBBR researchers recently received $3.9 million from the National Institutes of Health (NIH) to develop …
Published 10/24/18 on Tech Transfer eNews Blog Preclinical stage drug developer GEn1E Lifesciences has entered into a license agreement with the University of Maryland-Baltimore (UMB) to commercialize a treatment for acute lung injury/acute respiratory distress syndrome (ALI/ARDS). Developed by UMB …
Published 10/22/18 in Maryland Today The University of Maryland SAFE Center for Human Trafficking Survivors has been awarded a $843,337 grant from the Maryland Governor’s Office of Crime Control and Prevention to maintain and expand its services. The SAFE Center, a …